Giuliani, his Ukrainian middleman face increased scrutiny

Lev Parnas, a Ukrainian-American businessman who has been subpoenaed as part of the US House of Representatives' impeachment inquiry into President Donald Trump, has spent thousands of dollars on Trump properties and donated to the main super PAC supporting the President's reelection effort, according to documents produced in an unrelated federal lawsuit.

NRA's usual fans seeing differently

The pressure is on the National Rifle Association from typically friendly corners -- President Donald Trump and Republicans in Congress -- after last week's deadly mass shootings in Ohio and Texas.

Coke, Pepsi abandon plastics lobby

Coca-Cola and PepsiCo, two major sellers of plastic bottles, have made sweeping sustainability commitments. Now they are stepping away from a plasti

Trial for Michael Flynn's ex-lobbying partner starts

Prosecutors and defense attorneys spent the first day of the trial for retired Gen. Michael Flynn's ex-lobbying partner focused on a September 2016 meeting Flynn and others had with Turkish officials and an opinion piece Flynn published online on election day 2016.

Voting machine maker lobbies for paper ballots

The US's largest election equipment manufacturer has begun quietly lobbying Congress to force all voting equipment to create a paper trail, a sharp departure after years of selling paperless digital machines that can't be fully audited.

Australia reels from worst rampage killing in decades

On the long, bloody list of US gun violence, it would barely be a blip, but the killing of four people in northern Australia has caused shock in the country most often held up worldwide as an example of effective gun control.

Boeing a major lobbying player on Capitol Hill

Boeing, one of the world's largest aircraft manufacturers, also is one of the biggest players in the Washington influence game -- spending millions to lobby Congress and the executive branch each year.

Washington lobbying business surges to eight-year high

Lobbying activity in Washington surged to $3.4 billion last year -- its highest level since 2010 -- as companies, trade groups and other interests raced to shape policies on international trade, drug prices and other issues during President Donald Trump's second year in office, a new tally shows.